Home / Resource Library / Real-world cardiovascular risks of ibrutinib in chronic lymphocytic leukemia: a retrospective study

Real-world cardiovascular risks of ibrutinib in chronic lymphocytic leukemia: a retrospective study

Real world study investigated cardiovascular side effects of ibrutinib in CLL.